综述 Review

甲状腺癌分子标记物的研究进展

Published at: 2015年第35卷第6期

杨旭辉 1
1 华中科技大学同济医学院附属梨园医院普通外科,武汉 430077
通讯作者 旭辉 杨 Email: yangxuhui1979@163.com
DOI: 10.3978/j.issn.2095-6959.10.3978/j.issn.2095-6959.2015.06.054
基金:

摘要

近年来,大量甲状腺癌相关的分子标志物相继被发现。这些标志物也许可用来作为诊断的工具,或是预测患者的预后,甚至作为潜在的治疗靶点。比如在对甲状腺进行细针穿刺细胞学检查后,某些分子标志物可以协助诊断,为肿瘤的危险程度分级,进而优化甲状腺癌患者的手术方式以及术后的管理。


Research progress of thyroid cancer molecular markers

Abstract

In recent years, a large number of thyroid cancer related molecular markers have been found. These markers may be used as a diagnostic tool, or to predict the prognosis of patients, even as potential therapeutic targets. Such as in the thyroid fine needle puncture cytological examination, some molecular markers could help diagnose, to the degree of danger of tumor classification, thus optimizing the operation of thyroid carcinoma and postoperative management.


comments powered by Disqus

全文

引用

引用本文: 旭辉 杨. 甲状腺癌分子标记物的研究进展[J]. 临床与病理杂志, 2015, 35(6): 1148-1156.
Cite this article as: YANG Xuhui . Research progress of thyroid cancer molecular markers[J]. Journal of Clinical and Pathological Research, 2015, 35(6): 1148-1156.